Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 13, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2016 - 2020
Market Capitalization	24	16	26	33	46	3	Upgrade
Market Cap Growth	-52.63%	-37.80%	-21.42%	-27.28%	1300.12%	53.90%	Upgrade
Enterprise Value	21	13	22	27	38	0	Upgrade
Last Close Price	0.05	0.03	0.06	0.10	0.15	0.03	Upgrade
PB Ratio	3.23	1.76	1.34	1.66	1.86	0.33	Upgrade
P/TBV Ratio	4.65	5.79	4.85	5.76	7.00	1.52	Upgrade
Debt / Equity Ratio	0.03	0.04	0.01	0.01	0.01	0.05	Upgrade
Quick Ratio	0.07	0.12	2.73	2.32	3.47	0.01	Upgrade
Current Ratio	0.27	0.24	3.45	3.26	3.65	0.08	Upgrade
Return on Equity (ROE)	-90.95%	-98.52%	-48.70%	-48.81%	-28.87%	-10.46%	Upgrade
Return on Assets (ROA)	-24.43%	-33.60%	-26.18%	-17.26%	-16.59%	-5.78%	Upgrade
Return on Capital (ROIC)	-27.80%	-35.79%	-27.04%	-18.04%	-17.54%	-6.10%	Upgrade
Earnings Yield	-44.22%	-87.18%	-37.35%	-30.54%	-11.45%	-28.80%	Upgrade
FCF Yield	-6.26%	-24.40%	-13.38%	-16.53%	-6.94%	-5.75%	Upgrade
Buyback Yield / Dilution	1.18%	-10.29%	-9.01%	-56.21%	-49.58%	-10.91%	Upgrade

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.